Australia markets closed

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2700-0.0500 (-3.79%)
At close: 04:00PM EDT
1.3000 +0.03 (+2.36%)
After hours: 07:41PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
17,562
16,743
13,284
15,419
Cost of revenue
61,046
69,721
84,818
102,640
Gross profit
-43,484
-52,978
-71,534
-87,221
Operating expenses
Research development
148,048
159,120
90,852
50,717
Selling general and administrative
107,797
106,657
78,703
85,385
Total operating expenses
255,608
265,777
169,555
136,102
Operating income or loss
-299,092
-318,755
-241,089
-223,323
Interest expense
20,023
14,705
10,960
2,943
Total other income/expenses net
-30,256
-28,338
-10,686
-15,450
Income before tax
-349,299
-361,734
-262,243
-236,795
Income tax expense
17
51
-49
8
Income from continuing operations
-349,316
-361,785
-262,194
-236,803
Net income
-349,316
-361,785
-262,194
-236,803
Net income available to common shareholders
-349,316
-361,785
-262,194
-236,803
Basic EPS
-
-
-2.68
-2.42
Diluted EPS
-
-
-2.68
-2.42
Basic average shares
-
-
97,941
97,941
Diluted average shares
-
-
97,941
97,941
EBITDA
-
-326,334
-232,576
-218,653